Sources and review notes
These links support workflow-level research and do not establish the regulatory status, clinical safety, diagnostic performance, or suitability of any product.
ONC's Health IT Playbook describes population health management as identifying and monitoring individuals within defined groups and using aggregated data to support actionable clinical views, panel management, registries, care management, and public-health reporting. It also distinguishes population, practice or panel, and individual care-management levels. CMS defines accountable care around a care team taking responsibility for quality, coordination, outcomes, and costs for a defined group, while its Shared Savings Program publishes year-specific beneficiary-assignment, participant, quality, data-sharing, and financial specifications. Those program rules illustrate that attribution is a versioned operational definition rather than a permanent clinical fact, and they do not define every commercial, Medicaid, employer, public-health, community, or provider population. CMS quality-measure guidance requires explicit populations, denominators, exclusions, data sources, timing and, where specified, stratification; stratification can expose differences that aggregate rates hide and is not interchangeable with risk adjustment. CDC describes social determinants of health as non-medical conditions and wider forces that affect health outcomes, but a recorded social need or area-level proxy does not establish an individual's circumstance, diagnosis, eligibility, priority, or desired intervention. These sources do not validate an AI product, define one correct risk score or care-gap list, or prove that outreach, utilization reduction, closed gaps, financial performance, quality, equity, or health outcomes were caused by automation. Buyers should define each population by purpose, program, payer or contract, geography, attribution method and version, enrollment and observation windows, responsible organization and care team, inclusion and exclusion criteria, patient choice and consent where applicable, denominator and refresh cadence, available services and capacity, intended actions, outcome window, and stop criteria before selecting a model. Inventory EHR, claims, pharmacy, laboratory, HIE, registry, scheduling, engagement, community and patient-reported sources with identity-matching method, provenance, coverage, latency, correction process and known blind spots. Claims delay, out-of-network care, changing enrollment, duplicate identities, missing encounters, inconsistent coding, incomplete demographic and social data, and inaccessible services can change who appears eligible or high risk. Risk, utilization, cost, quality, care-gap and engagement scores should remain separate, versioned constructs with visible inputs, target and prediction horizon, training and validation population, calibration, thresholds, missing-data behavior, uncertainty, subgroup performance, explanation limits, action, override and appeal or correction path. They are prioritization inputs rather than diagnoses, prognoses, medical-necessity decisions, care plans, benefit determinations, or reasons to withhold care. Acceptance testing should use longitudinal known-answer cases across newly enrolled and disenrolled people, prospective and retrospective attribution, deceased and moved patients, duplicate and merged records, stale and corrected claims, recent discharge, multiple responsible teams, pregnancy and pediatric transitions, rare conditions, language and disability access, rural and transportation constraints, missing race, ethnicity and social data, conflicting care gaps, completed care outside the network, patient decline, unreachable patients, caregivers and proxies, urgent needs, source outages, limited outreach capacity, and model or measure version changes. Every surfaced item should retain the patient match, population and rule version, source facts and dates, reason and uncertainty, recommended workflow rather than clinical conclusion, responsible owner, due date, contact preference, outreach attempts, patient response, referral or service availability, action, escalation, correction, closure evidence, and unresolved state. Measure population and source coverage, matching errors, latency, gap and label validity, score discrimination and calibration, precision and missed high-need cases at operational capacity, subgroup error and selection rates, reviewer agreement and overrides, outreach attempts and successful contact, opt-outs, completed actions and closed-loop services, waiting time, staff workload, complaints, safety events, patient-reported burden, clinical and utilization outcomes, and total cost. Report denominators, confidence intervals where appropriate, case mix, data completeness, time windows, comparison method and attrition. More identified gaps, higher outreach volume, shorter queues, lower utilization, improved coding or contract savings do not alone establish appropriate care, better health, equity, compliance or causation. Governance should include qualified clinical, public-health, quality, data-science, privacy, security, legal, compliance, community and patient representation; lawful and minimal data use; role controls and audit logs; model and measure change review; prospective shadow testing; monitored rollout; accessible human alternatives; incident and bias response; rollback; data and decision export; and vendor-exit continuity. Automation must not fabricate missing facts, turn area-level proxies into individual facts, optimize only for reimbursable or easily contacted patients, suppress unfavorable outcomes, autonomously alter care plans or attribution, or make outreach, eligibility, coverage, diagnosis or treatment decisions without accountable review.
